5D Patient Journey, Inc.

Biotech New Rochelle, NY

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
New Rochelle, NY
Street
156 Beechmont Drive
Zip
10804

Offering

Total offering
$80
Amount sold
$80
First sale
Feb 19, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
4

How this filing compares

Ranked #20 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 0.0× the median.

Other New York filings this week: AM-0316 Fund I, a series of Nebular Expansion, LP, Ascendancy Fund, LP, Bayberry Onshore Fund LP, CanAm PIDC Regional Center, LP XXXVIII, COMMUNITY DEVELOPMENT TRUST INC

Leadership

Eric Schadt — Executive Officer (also: Director)

Filing details

5D Patient Journey, Inc. filed a Form D with the SEC on March 31, 2026.

Other newest Biotech companies

Other newest companies in New York